These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 130973)

  • 1. Letter: Calusterone (NSC-88536) in advanced breast cancer.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1976 Mar; 60(3):220-1. PubMed ID: 130973
    [No Abstract]   [Full Text] [Related]  

  • 2. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.
    Falkson G; van Dyk JJ; van Eden EB; van der Merwe AM; FALKSON HC
    Cancer Chemother Rep; 1974; 58(6):939-41. PubMed ID: 4615788
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical considerations on the use of a new synthetic androgen, Calusterone, in the treatment of advanced breast cancer].
    de Matteis A; Perrone V; Marone A
    Minerva Med; 1977 Jul; 68(36):2499-504. PubMed ID: 142218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calusterone (7-beta, 17-alpha-dimethyltestosterone) in the palliative treatment of advanced breast cancer].
    Robustelli Della Cuna G; Bernardo G; Strada MR
    Minerva Med; 1977 Oct; 68(52):3555-63. PubMed ID: 74052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calusterone therapy for advanced breast cancer.
    Aslam J; Maxwell I
    Cancer Treat Rep; 1977; 61(3):371-3. PubMed ID: 141327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trial hormone therapy of advanced breast cancers with calusterone. Preliminary study of 41 cases].
    Brule G; Chauvergne J; Clavel B; Gary-Bobo J; Gurrin J; Klein T; Pommatau E
    Sem Hop; 1974 Dec 8-14; 50(50-51):3099-105. PubMed ID: 4377318
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor activity of calusteron (NSC-88536) in advanced breast cancer.
    Rosso R; Porcile G; Brema F
    Cancer Chemother Rep; 1975; 59(5):890-1. PubMed ID: 128412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antitumoral activity of calusterone in advanced mammary carcinoma (author's transl)].
    Rosso R; Brema F; Porcile GF; Santi L
    Tumori; 1976; 62(1):79-84. PubMed ID: 138231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calusterone.
    Brodkin RA; Cooper MR
    Ann Intern Med; 1978 Dec; 89(6):945-8. PubMed ID: 152592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of 7 beta, 17 alpha-dimethyltestosterone (Calusterone) in advanced female breast cancer.
    Gordan GS; Halden A; Walter RM
    Calif Med; 1970 Sep; 113(3):1-10. PubMed ID: 5457511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 7beta, 17alpha-dimethyltestosterone (calusterone) on cortisol metabolism in women with advanced breast cancer.
    Fukushima DK; Zumoff B; Bulkin W; Hellman L
    J Clin Endocrinol Metab; 1976 Jul; 43(1):38-45. PubMed ID: 133118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7beta,17alpha-Dimethyltestosterone (calusterone)-induced changes in the metabolism, production rate, and excretion of estrogens in women with breast cancer: a possible mechanism of action.
    Fishman J; Hellman L
    J Clin Endocrinol Metab; 1976 Feb; 42(2):365-9. PubMed ID: 131130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calusterone for breast cancer.
    Med Lett Drugs Ther; 1973 Nov; 15(23):95. PubMed ID: 4746413
    [No Abstract]   [Full Text] [Related]  

  • 15. Calusterone (7beta,17alpha-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer.
    Gordan GS; Halden A; Horn Y; Fuery JJ; Parsons RJ; Walter RM
    Oncology; 1973; 28(2):138-46. PubMed ID: 4583006
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
    Ahmann DL; Bisel HF; Hahn RG
    Cancer Res; 1974 Jan; 34(1):27-30. PubMed ID: 4809462
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
    Umsawasdi T; Nilprabhassorn P
    J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
    [No Abstract]   [Full Text] [Related]  

  • 18. Male breast cancer: two cases with objective regressions from calusterone (7 alpha, 17 beta-dimethyltestosterone) after failure of orchiectomy.
    Horn Y; Roof B
    Oncology; 1976; 33(4):188-91. PubMed ID: 190574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer.
    Keating JL; Yonemoto RH; Byron RL
    Surg Gynecol Obstet; 1968 Sep; 127(3):538-42. PubMed ID: 4969618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.